Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-01-29 @ 2:05 PM
Study NCT ID:
NCT00656461
Status:
COMPLETED
Last Update Posted:
2009-11-25
First Post:
2008-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of MKC-1 in Patients With Advanced Cancer
Sponsor:
CASI Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MKC-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Miikana Therapeutics, an EntreMed, Inc. company